X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Natco Pharma with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NATCO PHARMA PIRAMAL ENTERPRISES NATCO PHARMA/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 31.0 38.9 79.6% View Chart
P/BV x 23.5 3.2 725.4% View Chart
Dividend Yield % 0.5 0.8 64.8%  

Financials

 NATCO PHARMA   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    NATCO PHARMA
Mar-14
PIRAMAL ENTERPRISES
Mar-17
NATCO PHARMA/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs8772,095 41.9%   
Low Rs4241,025 41.3%   
Sales per share (Unadj.) Rs223.4492.8 45.3%  
Earnings per share (Unadj.) Rs31.172.6 42.8%  
Cash flow per share (Unadj.) Rs40.394.7 42.5%  
Dividends per share (Unadj.) Rs5.0021.00 23.8%  
Dividend yield (eoy) %0.81.3 57.1%  
Book value per share (Unadj.) Rs219.5862.5 25.5%  
Shares outstanding (eoy) m33.07172.56 19.2%   
Bonus/Rights/Conversions PA--  
Price / Sales ratio x2.93.2 91.9%   
Avg P/E ratio x20.921.5 97.3%  
P/CF ratio (eoy) x16.116.5 98.0%  
Price / Book Value ratio x3.01.8 163.8%  
Dividend payout %16.128.9 55.6%   
Avg Mkt Cap Rs m21,504269,194 8.0%   
No. of employees `000NA4.0 0.0%   
Total wages/salary Rs m1,12817,939 6.3%   
Avg. sales/employee Rs ThNM21,190.3-  
Avg. wages/employee Rs ThNM4,470.1-  
Avg. net profit/employee Rs ThNM3,120.0-  
INCOME DATA
Net Sales Rs m7,38985,037 8.7%  
Other income Rs m1672,338 7.1%   
Total revenues Rs m7,55687,374 8.6%   
Gross profit Rs m1,79334,991 5.1%  
Depreciation Rs m3043,817 8.0%   
Interest Rs m36620,310 1.8%   
Profit before tax Rs m1,29013,202 9.8%   
Minority Interest Rs m461,699 2.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-100 0.0%   
Tax Rs m3092,281 13.5%   
Profit after tax Rs m1,02712,520 8.2%  
Gross profit margin %24.341.1 59.0%  
Effective tax rate %23.917.3 138.5%   
Net profit margin %13.914.7 94.4%  
BALANCE SHEET DATA
Current assets Rs m3,68187,590 4.2%   
Current liabilities Rs m3,123185,578 1.7%   
Net working cap to sales %7.6-115.2 -6.6%  
Current ratio x1.20.5 249.8%  
Inventory Days Days8931 288.3%  
Debtors Days Days5948 123.4%  
Net fixed assets Rs m7,685108,523 7.1%   
Share capital Rs m331345 95.8%   
"Free" reserves Rs m6,670148,481 4.5%   
Net worth Rs m7,259148,826 4.9%   
Long term debt Rs m955144,957 0.7%   
Total assets Rs m11,957482,394 2.5%  
Interest coverage x4.51.7 274.1%   
Debt to equity ratio x0.11.0 13.5%  
Sales to assets ratio x0.60.2 350.6%   
Return on assets %11.76.8 171.3%  
Return on equity %14.28.4 168.2%  
Return on capital %20.712.0 173.4%  
Exports to sales %39.40-   
Imports to sales %5.70-   
Exports (fob) Rs m2,908NA-   
Imports (cif) Rs m421NA-   
Fx inflow Rs m3,44515,001 23.0%   
Fx outflow Rs m7035,150 13.6%   
Net fx Rs m2,7439,851 27.8%   
CASH FLOW
From Operations Rs m1,440-100,393 -1.4%  
From Investments Rs m-1,089-24,202 4.5%  
From Financial Activity Rs m-353135,705 -0.3%  
Net Cashflow Rs m-111,110 -0.0%  

Share Holding

Indian Promoters % 52.0 52.9 98.4%  
Foreign collaborators % 1.5 0.0 -  
Indian inst/Mut Fund % 7.8 4.0 196.0%  
FIIs % 16.6 26.6 62.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.0 16.5 157.6%  
Shareholders   25,395 93,274 27.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NATCO PHARMA With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare NATCO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Share Markets Trade Flat; TCS Surges 3.5%(01:30 pm)

Indian share markets continued to trade on a flat note in the noon session. Gains are largely seen in software stocks, bank stocks and capital goods' stocks.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Jan 16, 2018 03:35 PM

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - SUVEN LIFE COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS